Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Djurfarmacia Sverige AB
AB
Active
Org 5567319321
Kungsgatan 57, 461 34
Trollhättan
Retail sale of pharmaceutical products
· NACE 4773
Est. 2007
48 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Djurfarmacia Sverige AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
160M
320M
480M
641M
328M
2021
361M
2022
419M
2023
466M
2024
557M
2025
EBITDA
SEK millions
0M
9M
18M
28M
37M
25M
2021
22M
2022
23M
2023
28M
2024
32M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
328 239
360 808
419 057
465 994
556 913
Staff expenses
—
−28 588
−31 559
−35 066
−40 708
EBITDA
25 335
21 791
22 966
27 691
32 378
Depreciation & amort.
−2 640
−908
−2 906
−2 957
−3 596
EBIT
22 695
20 883
20 060
24 733
28 783
Net financials
72
36
−201
72
343
Profit before tax
18 638
19 186
20 007
23 333
29 751
Tax
−4 013
−3 996
−4 226
−4 953
−6 250
Net profit
14 625
15 189
15 781
18 380
23 501
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
80 956
102 975
109 125
119 026
138 819
Equity
26 930
33 119
38 900
47 280
59 282
Long-term debt
0
3 600
0
—
—
Short-term debt
34 414
44 909
49 027
49 077
57 494
Total debt
34 414
48 509
49 027
49 077
57 494
Financial ratios
5-year trend
EBITDA margin
5.8%
This company
15.8%
Market median
-63% vs market
2021
2025
Equity ratio
42.7%
This company
38.2%
Market median
+12% vs market
2021
2025
Return on equity
39.6%
This company
18.4%
Market median
+115% vs market
2021
2025
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
2021
2025
Asset turnover
4.01×
This company
1.12×
Market median
+258% vs market
2021
2025
Debt / equity
1.34×
This company
0.62×
Market median
-116% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Djurfarmacia Sverige AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
